Mengyuan Yu

机构：Jiangnan University, Beijing University of Chinese Medicine, Second Affiliated Hospital of Jilin University, Shandong Provincial QianFoShan Hospital, Shandong First Medical University, Wuxi Institute of Technology, University of Birmingham, Henan Medical University, Shaanxi Normal University · ORCID：0000-0001-9908-5320

发表论文 69 篇 · 总被引 1102 次 · h-index 17

代表论文

• Correlation between atherogenic index of plasma and cardiovascular disease risk across Cardiovascular–kidney–metabolic syndrome stages 0–3: a nationwide prospective cohort study (2025 · Cardiovascular Diabetology · 被引 57)
• CD24 blockade as a novel strategy for cancer treatment (2023 · International Immunopharmacology · 被引 17)
• FGF21 promotes myocardial angiogenesis and mediates the cardioprotective effects of exercise in myocardial infarction mice (2023 · Journal of Applied Physiology · 被引 13)
• Mesenchymal stem cells overexpressing neuropeptide S promote the recovery of rats with spinal cord injury by activating the PI3K/AKT/GSK3β signaling pathway (2025 · Stem Cell Research & Therapy · 被引 11)
• Insulin-induced gene 2 protects against hepatic ischemia–reperfusion injury via metabolic remodeling (2023 · Journal of Translational Medicine · 被引 9)
• Vitamin E Treatment Improves the Antioxidant Capacity of Patients Receiving Dialysis: A Systematic Review and Meta‐Analysis (2023 · Molecular Nutrition & Food Research · 被引 7)